Hypercholesterolaemia Type II: Changes in Plasma Insulin and Glucagon Levels After Portacaval Shunt

Overview

Journal J Inherit Metab Dis

Publisher Wiley

Date 1980 Jan 1

PMID 6796760

Authors

J P Farriaux

A S Luyckx

M RIBET

Affiliations

Soon will be listed here.

Abstract

Insulinaemia and glucagonaemia were measured in two cases of hypercholesterolaemia type II, before and after portacaval shunt. The results show an increase of both hormones although these variations are not concomitant with the decrease in cholesterolaemia. The data still do not explain the mechanism of the decrease.

References

Starzl T, Watanabe K, Porter K, Putnam C . Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet. 1976; 1(7964):821-5. DOI: 10.1016/s0140-6736(76)90477-3. View

Starzl T, Lee I, Porter K, Putnam C . The influence of portal blood upon lipid metabolism in normal and diabetic dogs and baboons. Surg Gynecol Obstet. 1975; 140(3):381- 96. PMC: 2729190. View

Guzman I, Coyle J, Schneider P, VARCO R, Buchwald H . The effect of selective visceral caval shunt on plasma lipids and cholesterol dynamics. Surgery. 1977; 82(1):42-50. View

Quabbe H, Ramek W, Luyckx A . Growth hormone, glucagon, and insulin response to depression of plasma free fatty acids and the effect of glucose infusion. J Clin Endocrinol Metab. 1977; 44(2):383-91. DOI: 10.1210/jcem-44-2-383. View

Bilheimer D, Goldstein J, Grundy S, Brown M . Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia. J Clin Invest. 1975; 56(6):1420-30. PMC: 333120. DOI: 10.1172/JCI108223. View

AHRENS Jr E . Homozygous hypercholesteraemia and the portacaval shunt. The need for a concerted attack by surgeons and clinical researchers. Lancet. 1974; 2(7878):449-51. DOI: 10.1016/s0140-6736(74)91828-5. View

EATON R . Glucagon and lipoproteins. Metabolism. 1976; 25(11 Suppl 1):1415-7. DOI: 10.1016/s0026-0495(76)80154-0. View

Starzl T, Putnam C, Koep L . Portacaval shunt and hyperlipidemia. Arch Surg. 1978; 113(1):71-4. PMC: 3221468. DOI: 10.1001/archsurg.1978.01370130073012. View

Farriaux J, RIBET M, Bertrand M, Higgins M, Mazzuca M, Luyckx A . [Treatment of type II familial hypercholesteremia through portacaval anastomosis]. Arch Fr Pediatr. 1976; 33(8):745-59. View

10.

Weglicki W, Ganda O, Soeldner J, MURAWSKI B, Cohn L, Couch N . Portacaval diversion for severe hypercholesterolemia. Report of a case with measurements of glucose tolerance, insulin, and glucagon levels. Arch Surg. 1977; 112(5):634-6. DOI: 10.1001/archsurg.1977.01370050094016. View

11.

Marcel Y, Aubry F, Davignon J . [Effect of glucagon on cholesterol esterification and on blood cholesterol levels in normal and hyperlipidemic subjects]. Union Med Can. 1973; 102(4):876-83. View

12.

Goldstein J, Brown M . Atherosclerosis: the low-density lipoprotein receptor hypothesis. Metabolism. 1977; 26(11):1257-75. DOI: 10.1016/0026-0495(77)90119-6. View

13.

Jaspan J, Huen A, Morley C, Moossa A, Rubenstein A . The role of the liver in glucagon metabolism. J Clin Invest. 1977; 60(2):421-8. PMC: 372383. DOI: 10.1172/JCI108791. View

14.

Aubry F, Marcel Y, Davignon J . Effects of glucagon on plasma lipids in different types of primary hyperlipoproteinemia. Metabolism. 1974; 23(3):225-38. DOI: 10.1016/0026-0495(74)90061-4. View

15.

Kaden M, Harding P, Field J . Effect of intraduodenal glucose administration on hepatic extraction of insulin in the anesthetized dog. J Clin Invest. 1973; 52(8):2016-28. PMC: 302484. DOI: 10.1172/JCI107386. View

16.

Starzl T, Putnam C, Chase H, Porter K . Portacaval shunt in hyperlipoproteinaemia. Lancet. 1973; 2(7835):940-4. DOI: 10.1016/s0140-6736(73)92599-3. View